Does Saxenda mess with your hormones? Many people considering this weight-management medication wonder about its hormonal effects. Saxenda (liraglutide) works by mimicking GLP-1, a naturally occurring hormone that regulates appetite and blood sugar. Whilst it does not directly alter sex hormones like oestrogen or testosterone, it does influence metabolic hormones and can indirectly affect hormonal balance through weight loss. Understanding how Saxenda interacts with your body's hormonal systems helps you make informed decisions about treatment and recognise when to seek medical advice. This article explores Saxenda's hormonal mechanisms, effects on reproductive health, and guidance on managing potential side effects.

How Saxenda Works: Understanding Its Hormonal Mechanism

Saxenda (liraglutide) is a prescription medication licensed by the MHRA for weight management in adults with obesity or those who are overweight with weight-related health conditions. The medication works by mimicking a naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which is produced in the intestines in response to food intake.

When you inject Saxenda subcutaneously, it binds to GLP-1 receptors throughout the body, particularly in the pancreas, brain, and gastrointestinal tract. This hormonal action triggers several physiological responses:

• Appetite regulation: Saxenda acts on receptors in the hypothalamus (the brain's appetite control centre) to increase feelings of fullness and reduce hunger signals

• Delayed gastric emptying: The medication slows the rate at which food leaves the stomach, prolonging satiety after meals

• Insulin secretion: In the pancreas, Saxenda stimulates insulin release when blood glucose levels are elevated, whilst simultaneously suppressing glucagon (a hormone that raises blood sugar)

• Reduced food intake: Through these combined mechanisms, patients typically consume fewer calories, leading to gradual weight loss

It is important to understand that Saxenda does not directly alter sex hormones such as oestrogen, progesterone, or testosterone, nor does it directly affect thyroid hormone secretion. Rather, it works through the GLP-1 hormonal pathway, which is primarily involved in metabolic regulation. However, because weight loss itself can influence hormonal balance—particularly in conditions like polycystic ovary syndrome (PCOS)—some patients may notice indirect hormonal changes as they lose weight. The medication's hormonal mechanism is targeted and specific, designed to address appetite and glucose metabolism rather than reproductive or thyroid hormone systems.

Effects on Reproductive Hormones and Fertility

Whilst Saxenda does not directly interfere with reproductive hormones, weight loss achieved through the medication can have significant indirect effects on hormonal balance and fertility. This is particularly relevant for women with conditions such as PCOS, where excess weight contributes to hormonal imbalances, irregular menstrual cycles, and reduced fertility.

Weight loss and hormonal improvements: As patients lose weight on Saxenda, several positive hormonal changes may occur. Reduced body fat can lead to decreased insulin resistance, which in turn may help restore more regular ovulation in women with PCOS. Some women report that their menstrual cycles become more predictable after significant weight loss. Additionally, excess adipose tissue can influence oestrogen levels, so weight reduction may help normalise hormone balance in both men and women.

Fertility considerations: Women of childbearing potential should be aware that improved fertility may occur as weight decreases. If you are sexually active and not planning pregnancy, it is essential to use effective contraception whilst taking Saxenda. The medication should be discontinued if pregnancy is confirmed or planned, as there is insufficient safety data regarding liraglutide use during pregnancy. Discuss the timing of discontinuation with your prescriber if you are planning to conceive.

Contraceptive efficacy: Because Saxenda slows gastric emptying, there has been concern about whether it might affect the absorption of oral contraceptives. However, clinical studies have not demonstrated reduced effectiveness of oral contraceptive pills when taken alongside Saxenda. The UK product information confirms that liraglutide did not meaningfully reduce exposure to combined oral contraceptives. Nevertheless, if you experience severe gastrointestinal side effects such as persistent vomiting or diarrhoea, the absorption of oral contraceptives could potentially be compromised, and additional contraceptive measures should be considered.

Animal studies have shown C-cell thyroid tumours with liraglutide, though the relevance to humans is unknown. If you have a history of thyroid disease or notice symptoms such as neck lumps or hoarseness, discuss this with your healthcare provider.

Managing Hormonal Side Effects While Taking Saxenda

Whilst Saxenda's primary hormonal action targets the GLP-1 pathway, patients may experience side effects that feel hormonal in nature, particularly during the initial treatment phase. Understanding how to manage these effects can improve treatment adherence and overall wellbeing.

Common side effects and management strategies:

• Nausea and gastrointestinal symptoms: These are the most frequently reported side effects and occur because Saxenda slows gastric emptying. To minimise discomfort, eat smaller, more frequent meals, avoid high-fat foods, and stay well hydrated. The dose is gradually increased over five weeks specifically to allow your body to adjust to these effects.

• Fatigue and mood changes: Some patients report feeling more tired or experiencing mood fluctuations. While reduced calorie intake may contribute to these symptoms, GLP-1 medications have been associated with mood changes in some people. If you experience persistent low mood, depression, or thoughts of self-harm or suicide, seek medical advice promptly. The MHRA is currently reviewing reports of such effects with GLP-1 receptor agonists.

• Menstrual irregularities: If you notice changes to your menstrual cycle—whether more regular or temporarily disrupted—this is typically due to weight loss rather than direct hormonal interference from Saxenda. Keep a symptom diary to track patterns and discuss concerns with your GP.

Optimising treatment outcomes: To support your body through the metabolic and weight changes, maintain a balanced diet rich in whole foods, lean proteins, and vegetables. Regular physical activity not only enhances weight loss but also supports hormonal balance and mood regulation. The NHS recommends at least 150 minutes of moderate-intensity activity weekly.

Monitoring and adjustments: Your prescribing clinician should review your progress regularly. NICE guidance (TA664) recommends discontinuing Saxenda if you have not lost at least 5% of your initial body weight after 12 weeks at the maximum tolerated dose. If side effects become intolerable, discuss dose adjustment or alternative treatments with your healthcare provider. Never increase your dose faster than prescribed, and consult your prescriber before changing or stopping treatment. Do not use Saxenda alongside other GLP-1 receptor agonists.

If you experience persistent vomiting or diarrhoea, ensure you stay hydrated and seek medical advice, as dehydration can lead to kidney problems.

When to Seek Medical Advice About Hormonal Changes

Whilst most patients tolerate Saxenda well, certain symptoms warrant prompt medical attention. Understanding when to contact your GP or prescribing clinician ensures your safety and allows for timely intervention if complications arise.

Seek urgent medical advice if you experience:

• Severe abdominal pain: Particularly if persistent and radiating to the back, as this could indicate pancreatitis (inflammation of the pancreas), a rare but serious side effect. This may be accompanied by nausea, vomiting, and fever. If pancreatitis is suspected, stop Saxenda immediately and do not restart unless pancreatitis is ruled out.

• Symptoms of thyroid problems: Report any unusual neck swelling, persistent hoarseness, difficulty swallowing, or a lump in the neck to your doctor promptly.

• Signs of gallbladder disease: Rapid weight loss and GLP-1 medications can increase the risk of gallstones. Contact your GP if you develop severe upper right abdominal pain, especially after eating fatty meals, along with nausea or jaundice (yellowing of skin or eyes).

• Severe hypoglycaemia: If you also take medications for type 2 diabetes (particularly insulin or sulphonylureas), watch for symptoms of low blood sugar including trembling, sweating, confusion, rapid heartbeat, or dizziness. Your prescriber may need to reduce doses of these medications to prevent hypoglycaemia.

• Allergic reactions: Seek immediate medical care for swelling of the face, lips, or tongue, difficulty breathing, or severe rash, which could indicate a serious allergic reaction.

Routine monitoring appointments: Schedule a review with your prescriber if you notice significant menstrual changes that concern you, unexplained mood disturbances lasting more than two weeks, or persistent fatigue that interferes with daily activities. Women who suspect they may be pregnant should stop Saxenda immediately and contact their healthcare provider.

Pre-existing hormonal conditions: If you have diagnosed thyroid disorders, PCOS, or other endocrine conditions, inform your prescriber before starting Saxenda. These conditions require closer monitoring during treatment, and your specialist may wish to check relevant hormone levels periodically.

Your GP can arrange appropriate investigations, which may include blood tests to assess thyroid function, reproductive hormones, or metabolic markers. Always attend scheduled follow-up appointments and maintain open communication with your prescribing clinician about any concerns regarding hormonal or other side effects.

Report any suspected side effects to the MHRA through the Yellow Card Scheme (yellowcard.mhra.gov.uk or the Yellow Card app).

Frequently Asked Questions